Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Lone Tree CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Lone Tree CO, Grand Island NE, Salt Lake City UT,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for
Metastatic Colorectal Cancer
Location: Lone Tree CO, Abilene TX, Bedford TX, Columbia MO,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT07549412
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Lone Tree CO, Phoenix AZ, Rochester MN, Temple TX,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Lone Tree CO, Fort Collins CO, Farmington NM, Ogden UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Lone Tree CO, Phoenix AZ, Fort Worth TX, Dallas TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase 1, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Lone Tree CO, Grand Island NE, Dallas TX, Burnsville MN,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
for
Small Cell Lung Cancer Extensive Stage
Location: Lone Tree CO, Dallas TX, Tyler TX, St Louis MO,
Sponsor: Genprex, Inc.
Sex: All
Age: 18+
Code: NCT05703971
Phase 1, Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Lone Tree CO, Albuquerque NM, Fort Bliss TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Location: Denver CO, San Diego CA, Houston TX, Milwaukee WI,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT04718168
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Parker CO, Yukon OK, Kansas City KS, Las Vegas NV,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
New
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: Boulder CO, San Antonio TX, Beaumont TX, Winchester VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
for
Actinic Keratosis
Location: Castle Rock CO, Saint Joseph MO, Phoenix AZ, Boise ID,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144852
Phase 3, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Castle Rock CO, Oklahoma City OK, Scottsdale AZ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase 3, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
for
Prurigo Nodularis
Location: Castle Rock CO, Lee's Summit MO, Phoenix AZ, Tucson AZ,
Sponsor: Galderma R&D
Sex: All
Age: 18+
Code: NCT06988618
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Boulder CO, Kansas City KS, Phoenix AZ, Austin TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Boulder CO, Kansas City KS, Phoenix AZ, Frisco TX,